Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas. - sprookjes - yvandenbroek - TriplyDB

Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas.

Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas.

http://www.wikidata.org/entity/Q34491021

about

The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future.Combining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials.New therapeutic targets in soft tissue sarcoma.Combining targeted agents with modern radiotherapy in soft tissue sarcomas.Emerging therapies for adult soft tissue sarcoma.A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma.Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer.Long-term Oncologic Outcomes After Neoadjuvant Radiation Therapy for Retroperitoneal Sarcomas.Surgical management of retroperitoneal and pelvic sarcomas.CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression.Texture Analysis of Non-Contrast-Enhanced Computed Tomography for Assessing Angiogenesis and Survival of Soft Tissue Sarcoma.Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculature Hypoxia-activated chemotherapeutic TH-302 enhances the effects of VEGF-A inhibition and radiation on sarcomas.The novel antiangiogenic VJ115 inhibits the NADH oxidase ENOX1 and cytoskeleton-remodeling proteins Molecular targeted therapies in non-GIST soft tissue sarcomas: what the radiologist needs to know Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03).Antiangiogenic approach in soft-tissue sarcomas.Management of recurrent retroperitoneal sarcoma.Hypoxia-inducible factors: mediators of cancer progression; prognostic and therapeutic targets in soft tissue sarcomas.The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets.Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α.Molecular Predictors of Radiotherapy Response in Sarcoma.Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies.Advances in Radiation Therapy for Primary and Metastatic Adult Soft Tissue Sarcomas.Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas.Optimization of arterial spin labeling MRI for quantitative tumor perfusion in a mouse xenograft model.Response assessment to neoadjuvant therapy in soft tissue sarcomas: using CT texture analysis in comparison to tumor size, density, and perfusion.Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts.Combined radiation therapy and sunitinib for preoperative treatment of soft tissue sarcoma.

P2860

Q33705268-FB343A4B-4BCC-4F84-8B9D-43C7238CF227 Q33802617-78E70903-C3DE-495F-A3D2-E20AE94BCC88 Q34267924-919CC732-8F75-40DD-95F5-DA9B5881D703 Q34396047-009BD5A7-06D9-44A0-8139-17A80E5B69A4 Q34659806-79D01E0D-ED12-438E-A621-EB7CBCAFE9F1 Q34687036-85A914FB-1928-4859-8C4B-AD3DD6C5EF53 Q35062862-9855B3E7-1E1E-4DB8-876D-735EEB4CF73F Q35133368-30BE8E06-F695-4CD2-BF30-EAA139DDF7B3 Q35224619-EB32573A-2B54-4647-8B55-F6A19BFDB852 Q35776891-43C0C6EC-59E7-4C2A-95B7-7ABCCB6E2408 Q35858640-37BCCA3D-EDB2-4A7D-B550-AA5F7614C9FF Q36027155-5A52A9C3-B7C1-4F96-8597-AB1471CD2461 Q36286658-33FB0B36-579E-4BAF-82FA-824B4CAD9C64 Q36556901-0464DBB5-ECD0-4CD1-B4E4-60FDFFD5AA01 Q36819466-650FD790-4A22-4F8F-AA2E-BCA0A533A444 Q36965629-ABFB71D7-A07B-446F-BEC5-B9DED08013F2 Q38128896-F1065CB5-2F55-428F-805B-7F66467E960A Q38155133-EDC5C87F-16FA-4929-8AEC-4DDE1F95D717 Q38161730-8E8F4B6D-36EF-4C90-BE3C-53CF9F7D526E Q38252537-72CAD6DC-9ACD-4298-B35E-927DCC442D63 Q38496656-84259B83-E68B-4779-ABAC-1FD80668AB44 Q38682324-E48D6013-AEC0-4D90-870A-18F8840CB710 Q38683248-90E67D52-0B82-414A-85F9-F8FC1C1318FE Q38817376-2DFCD90C-6163-421C-9CF1-994C0B4848D5 Q38840133-E3888EC9-6398-421D-A800-72D1A2A7A505 Q38860709-0E507D56-BE90-4968-BC4A-DC95963D9596 Q47417267-2285C8C4-72E6-4A8F-BEBC-2A55266A1CD8 Q48348656-DED40254-5194-4F03-AF88-8CCDCC6681F5 Q53464347-AB87DE68-67E4-46AA-8E77-92C4927DB5C3

P2860

Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas.

http://www.wikidata.org/entity/Q34491021

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Phase II study of neoadjuvant ...... sectable soft tissue sarcomas.

@ast

Phase II study of neoadjuvant ...... sectable soft tissue sarcomas.

@en

Phase II study of neoadjuvant ...... sectable soft tissue sarcomas.

@nl

type

label

Phase II study of neoadjuvant ...... sectable soft tissue sarcomas.

@ast

Phase II study of neoadjuvant ...... sectable soft tissue sarcomas.

@en

Phase II study of neoadjuvant ...... sectable soft tissue sarcomas.

@nl

prefLabel

Phase II study of neoadjuvant ...... sectable soft tissue sarcomas.

@ast

Phase II study of neoadjuvant ...... sectable soft tissue sarcomas.

@en

Phase II study of neoadjuvant ...... sectable soft tissue sarcomas.

@nl

P1433

Q34491021-0FA7905B-7137-4303-B51B-B8C9CBD0963B

P1476

Q34491021-FC251087-07D7-4CB8-9E9F-17805E1E48C2

P2093

Q34491021-0B36C62D-E592-40FF-A204-AA28715B9EB2

Q34491021-130C6857-FF82-4535-B409-C2D678C15706

Q34491021-337C5193-2A85-4A01-9848-C57A33CF2F46

Q34491021-39EB424C-ABBE-4680-8E43-6D372F02CC48

Q34491021-3BBF105E-82C5-4C31-A632-1F7AB6A82A0E

Q34491021-4D50B705-9ACF-43B3-A8AC-83527EECCF5C

Q34491021-5068E29B-3564-4D56-856C-439A6CED67E5

Q34491021-5A7DA2D7-7A6C-46A7-A55E-A23DF50E3A66

Q34491021-5D3E5345-8E84-46FA-9805-6FDDE0FEFC3C

Q34491021-6680199C-4CDD-4B7F-A063-5773C187F950

P2860

Q34491021-0158B86F-3D3B-43CC-85CC-4F05D27BB776

Q34491021-0BF90BFD-009D-421F-AB76-6129C7355703

Q34491021-11BB1920-6F9F-45F2-90CA-AF2B3B349FF7

Q34491021-2FC81E4A-14DF-4B1C-A83E-B59FB77734A5

Q34491021-48E8EC80-D388-4103-949A-5CA63BA7DEB4

Q34491021-4AF0CF60-7C29-4D51-9693-2391F1E7638E

Q34491021-50AB9BC0-D4BB-49E9-BB11-FF87EBA51C61

Q34491021-54B64831-B5A4-4C37-A266-87029E7500A3

Q34491021-55C4117B-97E9-4A1A-96B7-33B8E3927B34

Q34491021-5CBB7835-4793-436A-A72C-872197ECE5EA

P304

Q34491021-65045B1B-F0E7-4235-8C7C-12E8D5B497C1

P31

Q34491021-DFFE4DF7-3C45-4441-98C9-B5966143C363

P356

Q34491021-B3A64811-DD14-45A2-BC4C-C44C15D8D0F5

P407

Q34491021-5C0E212B-B8CF-40E4-BEB4-03F32E778AA8

P433

Q34491021-06AC7622-F78B-44EF-BAC4-A0E98B9BD114

P478

Q34491021-B61F6820-B651-43F3-BA3D-6B34A3C0FC99

P50

Q34491021-F4047CB2-B5AC-4D49-A1F3-8B5363715B8A

P577

Q34491021-D8FD7D71-2FFE-4366-8DD0-4A564A8D625A

P5875

Q34491021-9CBFBE51-F9B3-4EEB-9858-2DED3AC04A3A

P698

Q34491021-5581DF0C-4765-46AE-9B47-E4CE0003AED0

P921

Q34491021-47FA39AE-6851-465F-AE24-F3975D9469E7

Q34491021-9C56BB9A-5105-49CB-B14E-50BA399B940B

P932

Q34491021-5372CDD7-68FD-4E62-A225-FB3B1DA99571

P356

J.IJROBP.2010.07.024

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Phase II study of neoadjuvant ...... sectable soft tissue sarcomas.

@en

P2093

Andrew E Rosenberg

http://www.w3.org/2001/XMLSchema#string

Avinash R Kambadakone

http://www.w3.org/2001/XMLSchema#string

Courtney Rothrock

http://www.w3.org/2001/XMLSchema#string

Dan G Duda

http://www.w3.org/2001/XMLSchema#string

Daniel L Karl

http://www.w3.org/2001/XMLSchema#string

David C Harmon

http://www.w3.org/2001/XMLSchema#string

David G Kirsch

http://www.w3.org/2001/XMLSchema#string

Dushyant V Sahani

http://www.w3.org/2001/XMLSchema#string

Francis J Hornicek

http://www.w3.org/2001/XMLSchema#string

G Petur Nielsen

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial

Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas

Biomarkers of response and resistance to antiangiogenic therapy.

A prospective randomized trial of adjuvant brachytherapy in the management of low-grade soft tissue sarcomas of the extremity and superficial trunk.

Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.

Retroperitoneal sarcomas: combined modality treatment approaches.

Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.

Expanding the clinical development of bevacizumab.

Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations.

Gene expression profiling in sarcomas.

P304

1081-1090

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2010.07.024

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47381878

http://www.w3.org/2001/XMLSchema#string

P698

20932656

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3021107

http://www.w3.org/2001/XMLSchema#string